Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -32.61% | 62.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.99% | 32.86% | |||
| Operating Income | 3.99% | -32.86% | |||
| Income Before Tax | -181.03% | -32.99% | |||
| Income Tax Expenses | -206,825.00% | -96.23% | |||
| Earnings from Continuing Operations | -131.21% | -31.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -131.21% | -31.91% | |||
| EBIT | 3.99% | -32.86% | |||
| EBITDA | 3.99% | -32.84% | |||
| EPS Basic | -127.17% | 42.87% | |||
| Normalized Basic EPS | 4.95% | 42.37% | |||
| EPS Diluted | -127.17% | 42.87% | |||
| Normalized Diluted EPS | 4.95% | 42.37% | |||
| Average Basic Shares Outstanding | 1.74% | 131.01% | |||
| Average Diluted Shares Outstanding | 1.74% | 131.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||